Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Initial observations and problems with in vitro predictive assay in genitourinary malignancies.

A Zabbo, J E Montie, G T Budd

    Urology
    |April 1, 1984
    PubMed
    Summary

    The clonogenic assay shows promise for in vitro chemosensitivity testing of genitourinary tumors. However, challenges with obtaining adequate viable cells and drawing clinical correlations require further study.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Developing a Patient-Centered Model of Prostate Cancer Care: Patient Satisfaction With a Survivorship Program Embedded in Urologic-Oncologic Care.

    Urology·2021
    Same author

    SWOG S0800 (NCI CDR0000636131): addition of bevacizumab to neoadjuvant nab-paclitaxel with dose-dense doxorubicin and cyclophosphamide improves pathologic complete response (pCR) rates in inflammatory or locally advanced breast cancer.

    Breast cancer research and treatment·2016
    Same author

    Variation in the use of postoperative radiotherapy among high-risk patients following radical prostatectomy.

    Prostate cancer and prostatic diseases·2016
    Same author

    Germline genetic variants in ABCB1, ABCC1 and ALDH1A1, and risk of hematological and gastrointestinal toxicities in a SWOG Phase III trial S0221 for breast cancer.

    The pharmacogenomics journal·2013
    Same author

    Impact of premenopausal status at breast cancer diagnosis in women entered on the placebo-controlled NCIC CTG MA17 trial of extended adjuvant letrozole.

    Annals of oncology : official journal of the European Society for Medical Oncology·2012
    Same author

    Interobserver consistency of digital rectal examination in clinical staging of localized prostatic carcinoma.

    Urologic oncology·2011

    Area of Science:

    • Oncology
    • Cell Biology
    • Medical Diagnostics

    Background:

    • Advances in in vitro techniques enable human malignancy growth and chemosensitivity testing.
    • The clonogenic assay, a colony-forming assay, is being evaluated for genitourinary malignancies.

    Purpose of the Study:

    • To report initial experiences with the clonogenic assay for genitourinary tumors.
    • To assess the feasibility and challenges of applying this assay to clinical samples.

    Main Methods:

    • 172 genitourinary tumor specimens were analyzed over two years.
    • Cell viability was assessed using trypan blue exclusion.
    • Adequate cell growth was determined for chemosensitivity testing.

    Main Results:

    Related Experiment Videos

    • 33% of specimens were not plated due to insufficient cell quantity or low viability.
    • 47% demonstrated adequate growth for chemosensitivity testing.
    • 20% showed inadequate growth, highlighting challenges in cell acquisition.

    Conclusions:

    • Obtaining sufficient viable cells remains a significant hurdle.
    • Difficulties in establishing clinical correlations necessitate further research.
    • The clonogenic assay shows potential but requires additional studies to define its clinical utility.